155 related articles for article (PubMed ID: 22492853)
1. Parvovirus 4 infection and clinical outcome in high-risk populations.
Simmons R; Sharp C; McClure CP; Rohrbach J; Kovari H; Frangou E; Simmonds P; Irving W; Rauch A; Bowness P; Klenerman P;
J Infect Dis; 2012 Jun; 205(12):1816-20. PubMed ID: 22492853
[TBL] [Abstract][Full Text] [Related]
2. High frequency, sustained T cell responses to PARV4 suggest viral persistence in vivo.
Simmons R; Sharp C; Sims S; Kloverpris H; Goulder P; Simmonds P; Bowness P; Klenerman P
J Infect Dis; 2011 May; 203(10):1378-87. PubMed ID: 21502079
[TBL] [Abstract][Full Text] [Related]
3. High prevalence of human parvovirus 4 infection in HBV and HCV infected individuals in shanghai.
Yu X; Zhang J; Hong L; Wang J; Yuan Z; Zhang X; Ghildyal R
PLoS One; 2012; 7(1):e29474. PubMed ID: 22235298
[TBL] [Abstract][Full Text] [Related]
4. High frequencies of exposure to the novel human parvovirus PARV4 in hemophiliacs and injection drug users, as detected by a serological assay for PARV4 antibodies.
Sharp CP; Lail A; Donfield S; Simmons R; Leen C; Klenerman P; Delwart E; Gomperts ED; Simmonds P
J Infect Dis; 2009 Oct; 200(7):1119-25. PubMed ID: 19691429
[TBL] [Abstract][Full Text] [Related]
5. Immunoglobulin G and M antibodies to human parvovirus 4 (PARV4) are frequently detected in patients with HIV-1 infection.
Yang SJ; Hung CC; Chang SY; Lee KL; Chen MY
J Clin Virol; 2011 May; 51(1):64-7. PubMed ID: 21353629
[TBL] [Abstract][Full Text] [Related]
6. Serodiagnosis of primary infections with human parvovirus 4, Finland.
Lahtinen A; Kivelä P; Hedman L; Kumar A; Kantele A; Lappalainen M; Liitsola K; Ristola M; Delwart E; Sharp C; Simmonds P; Söderlund-Venermo M; Hedman K
Emerg Infect Dis; 2011 Jan; 17(1):79-82. PubMed ID: 21192859
[TBL] [Abstract][Full Text] [Related]
7. Low Prevalence of Parvovirus 4 in HIV-infected Children in Denmark.
Rosenfeldt V; Norja P; Lindberg E; Jensen L; Hedman L; Väisänen E; Li X; Hedman K; von Linstow ML
Pediatr Infect Dis J; 2015 Jul; 34(7):761-2. PubMed ID: 25545184
[TBL] [Abstract][Full Text] [Related]
8. Absence of novel human parvovirus (PARV4) in Danish mothers and children.
von Linstow ML; Rosenfeldt V; Lindberg E; Jensen L; Hedman L; Li X; Väisänen E; Hedman K; Norja P
J Clin Virol; 2015 Apr; 65():23-5. PubMed ID: 25766982
[TBL] [Abstract][Full Text] [Related]
9. Testing UK blood donors for exposure to human parvovirus 4 using a time-resolved fluorescence immunoassay to screen sera and Western blot to confirm reactive samples.
Maple PA; Beard S; Parry RP; Brown KE
Transfusion; 2013 Oct; 53(10 Pt 2):2575-84. PubMed ID: 23721256
[TBL] [Abstract][Full Text] [Related]
10. Human parvovirus 4 infection among mothers and children in South Africa.
Matthews PC; Sharp CP; Malik A; Gregory WF; Adland E; Jooste P; Goulder PJ; Simmonds P; Klenerman P
Emerg Infect Dis; 2015 Apr; 21(4):713-5. PubMed ID: 25812109
[No Abstract] [Full Text] [Related]
11. Evolution of CD8+ T cell responses after acute PARV4 infection.
Simmons R; Sharp C; Levine J; Bowness P; Simmonds P; Cox A; Klenerman P
J Virol; 2013 Mar; 87(6):3087-96. PubMed ID: 23283958
[TBL] [Abstract][Full Text] [Related]
12. Human parvovirus 4 infection, Cameroon.
Lavoie M; Sharp CP; Pépin J; Pennington C; Foupouapouognigni Y; Pybus OG; Njouom R; Simmonds P
Emerg Infect Dis; 2012 Apr; 18(4):680-3. PubMed ID: 22469425
[TBL] [Abstract][Full Text] [Related]
13. First report of human parvovirus 4 detection in Iran.
Asiyabi S; Nejati A; Shoja Z; Shahmahmoodi S; Jalilvand S; Farahmand M; Gorzin AA; Najafi A; Haji Mollahoseini M; Marashi SM
J Med Virol; 2016 Aug; 88(8):1314-8. PubMed ID: 26812938
[TBL] [Abstract][Full Text] [Related]
14. Study on the blood-borne virus co-infection and T lymphocyte subset among intravenous drug users.
Li JR; Gong RY; Tian KL; Wang J; Wang YX; Huang HJ
World J Gastroenterol; 2007 Apr; 13(16):2357-62. PubMed ID: 17511038
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and association of human parvovirus B19V with hepatitis B and C viruses in Nigeria.
Opaleye OO; Fagbami AH; Lalremruata A; Kun JF
J Med Virol; 2011 Apr; 83(4):710-6. PubMed ID: 21328387
[TBL] [Abstract][Full Text] [Related]
16. High seroprevalence of parvovirus B19 among patients infected with human immunodeficiency virus.
Vernazza PL; Pfister LA; Siegl G; Cassinotti P
Clin Infect Dis; 1996 Jan; 22(1):198-9. PubMed ID: 8825012
[No Abstract] [Full Text] [Related]
17. Comparison of tissue distribution, persistence, and molecular epidemiology of parvovirus B19 and novel human parvoviruses PARV4 and human bocavirus.
Manning A; Willey SJ; Bell JE; Simmonds P
J Infect Dis; 2007 May; 195(9):1345-52. PubMed ID: 17397006
[TBL] [Abstract][Full Text] [Related]
18. Epidemiology of human herpesvirus type 8 and parvovirus B19 infections and their association with HIV-1 among men who have sex with men and injection drug users in Taiwan.
Lee YM; Chuang SY; Wang SF; Lin YT; Chen YM
J Microbiol Immunol Infect; 2014 Jun; 47(3):233-8. PubMed ID: 23465711
[TBL] [Abstract][Full Text] [Related]
19. Is routine viral screening useful in patients with recent-onset polyarthritis of a duration of at least 6 weeks? Results from a nationwide longitudinal prospective cohort study.
Varache S; Narbonne V; Jousse-Joulin S; Guennoc X; Dougados M; Daurès JP; Devauchelle-Pensec V; Saraux A
Arthritis Care Res (Hoboken); 2011 Nov; 63(11):1565-70. PubMed ID: 21954118
[TBL] [Abstract][Full Text] [Related]
20. Human parvovirus 4 prevalence among HTLV-1/2 infected individuals in Brazil.
Slavov SN; Otaguiri KK; Smid J; de Oliveira AC; Casseb J; Martinez EZ; Covas DT; Eis-Hübinger AM; Kashima S
J Med Virol; 2017 Apr; 89(4):748-752. PubMed ID: 27589576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
